HTGC icon

Hercules Capital

20.08 USD
+0.22
1.11%
At close Dec 27, 4:00 PM EST
After hours
20.00
-0.08
0.40%
1 day
1.11%
5 days
5.80%
1 month
6.30%
3 months
1.67%
6 months
-0.99%
Year to date
20.02%
1 year
18.61%
5 years
42.41%
10 years
33.78%
 

About: Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.

Employees: 100

0
Funds holding %
of 6,812 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

53% more repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 77

26% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 31

3% more funds holding

Funds holding: 283 [Q2] → 291 (+8) [Q3]

1.17% less ownership

Funds ownership: 20.9% [Q2] → 19.74% (-1.17%) [Q3]

9% less capital invested

Capital invested by funds: $686M [Q2] → $622M (-$64M) [Q3]

15% less call options, than puts

Call options by funds: $14M | Put options by funds: $16.4M

17% less funds holding in top 10

Funds holding in top 10: 6 [Q2] → 5 (-1) [Q3]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$21
5%
upside
Avg. target
$22
7%
upside
High target
$22
10%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Keefe, Bruyette & Woods
Paul Johnson
64% 1-year accuracy
7 / 11 met price target
7%upside
$22
Outperform
Upgraded
12 Dec 2024
JMP Securities
Brian McKenna
58% 1-year accuracy
7 / 12 met price target
10%upside
$22
Market Outperform
Reiterated
6 Dec 2024
Wells Fargo
Finian O'Shea
61% 1-year accuracy
22 / 36 met price target
5%upside
$21
Overweight
Maintained
29 Oct 2024

Financial journalist opinion

Based on 9 articles about HTGC published over the past 30 days

Neutral
Zacks Investment Research
9 hours ago
Hercules Capital (HTGC) Rises As Market Takes a Dip: Key Facts
Hercules Capital (HTGC) concluded the recent trading session at $20.08, signifying a +1.11% move from its prior day's close.
Hercules Capital (HTGC) Rises As Market Takes a Dip: Key Facts
Negative
Seeking Alpha
20 hours ago
Very Bad News For BDCs, But There Is A Solution
BDCs are currently exposed to multiple structural headwinds. It is very difficult to substantiate a bullish case for the BDC sector. In my view, to achieve alpha, one would have to go far out on the risk curve.
Very Bad News For BDCs, But There Is A Solution
Positive
Zacks Investment Research
2 days ago
Is Hercules Capital (HTGC) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Is Hercules Capital (HTGC) a Buy as Wall Street Analysts Look Optimistic?
Positive
Seeking Alpha
3 days ago
Hercules Capital: A Magnificent BDC Gem
Hercules Capital's premium to NAV is justified by its strong two-decade performance, technology focus, and potential for record-breaking growth in 2025. The BDC's high recurring interest income and supplemental dividends make it a reliable choice for passive income investors. Hercules Capital's technology-oriented investments, including equity stakes in successful companies, offer significant long-term upside potential.
Hercules Capital: A Magnificent BDC Gem
Neutral
PRNewsWire
1 week ago
Remodel Health Raises More Than $100 Million to Continue Expansion in ICHRA Market
INDIANAPOLIS , Dec. 19, 2024 /PRNewswire/ -- Remodel Health , the #1 Individual Coverage Health Reimbursement Arrangement (ICHRA) provider for brokers, today announced it has raised more than $100 million from Oak HC/FT and Hercules Capital, Inc. (NYSE: HTGC)  in growth funding. Remodel Health has raised more than $100 million from Oak HC/FT and Hercules Capital, Inc. in growth funding.
Remodel Health Raises More Than $100 Million to Continue Expansion in ICHRA Market
Positive
Seeking Alpha
2 weeks ago
Invest In $95,000 BDC Portfolio For $10,000 Annual Income And Durable Compounding
Private credit/BDC investments offer exposure to structural growth and a significant portfolio yield enhancement. Yet, we have to be extra careful of not falling into value traps and investing in unsustainable yields, which are abundant in the inherently risky sector. In this article, I share a BDC portfolio that has ~10.5% yield, healthier fundamentals than the average in the space, and, importantly, meaningful price appreciation potential.
Invest In $95,000 BDC Portfolio For $10,000 Annual Income And Durable Compounding
Positive
Seeking Alpha
3 weeks ago
Hercules Capital: Are The Dividends Safe? I'm Buying!
Hercules Capital offers an attractive income yield (~8.4% regular dividends) and focuses on US businesses in technology, life sciences, SaaS, and renewable technology sectors. Since Hercules Capital offers attractive distributions (including supplemental dividends), investors should examine the safety of its payments, as HTGC is sensitive to FED policy. I provided a sensitivity analysis of Hercules dividend coverage, taking into account different interest-level scenarios, including both the reduction of its income and the lower cost of debt.
Hercules Capital: Are The Dividends Safe? I'm Buying!
Negative
Zacks Investment Research
3 weeks ago
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet
Neutral
Business Wire
3 weeks ago
Hercules Capital Renews and Increases Its Multi-Currency SMBC Credit Facility to $300.0 Million
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has renewed and upsized its existing $225.0 million credit facility with Sumitomo Mitsui Banking Corporation (“SMBC”) with an upsized credit facility under which Syn.
Hercules Capital Renews and Increases Its Multi-Currency SMBC Credit Facility to $300.0 Million
Positive
Seeking Alpha
1 month ago
Hercules Capital: This 10% Yield Is Rock Solid
Hercules Capital offers a 10% dividend yield, supported by strong balance sheet quality and low non-accrual percentage of 0.6%. The BDC focuses on venture-backed tech companies, achieving consistent growth in total investment income. Despite a 66% premium to NAV, Hercules Capital's robust dividend coverage and record total investment income justify the valuation.
Hercules Capital: This 10% Yield Is Rock Solid
Charts implemented using Lightweight Charts™